PROCEPT BioRobotics Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $308.1M | $224.5M | $136.2M | $75.0M | $34.5M |
| Cost of revenue | $111.8M | $87.4M | $65.1M | $37.9M | $18.6M |
| Gross profit | $196.2M | $137.1M | $71.0M | $37.1M | $15.9M |
| Selling, general & administrative | $228.8M | $171.4M | $131.8M | $88.8M | $51.0M |
| Research and development | $71.3M | $62.3M | $48.4M | $29.0M | $19.0M |
| Operating expenses | $300.1M | $233.7M | $180.2M | $117.8M | $70.0M |
| Operating income | -$103.9M | -$96.6M | -$109.2M | -$80.7M | -$54.2M |
| Interest expense | $3.6M | $4.2M | $4.0M | $5.2M | $5.8M |
| Pretax income | -$95.4M | -$91.0M | -$105.8M | — | — |
| Income tax expense | $190,000 | $368,000 | $80,000 | $0 | $0 |
| Net income | -$95.6M | -$91.4M | -$105.9M | -$87.2M | -$59.9M |
| Balance Sheet | |||||
| Cash and equivalents | $286.5M | $333.7M | $257.2M | $221.9M | $304.3M |
| Current assets | $450.4M | $481.8M | $350.6M | $272.6M | $326.2M |
| Total assets | $508.1M | $534.0M | $404.7M | $309.3M | $337.0M |
| Current liabilities | $65.8M | $53.1M | $45.9M | $35.3M | $16.2M |
| Total liabilities | $142.2M | $131.8M | $124.0M | $112.3M | $69.9M |
| Total debt | $52.0M | $52.0M | $52.0M | $52.0M | $50.0M |
| Stockholders' equity | $365.9M | $402.2M | $280.8M | $197.1M | $267.1M |
| Cash Flow Statement | |||||
| Cash from operations | -$49.0M | -$99.2M | -$108.0M | -$80.4M | -$57.3M |
| Depreciation and amortization | $6.4M | $5.2M | $3.8M | $2.8M | $3.3M |
| Stock-based compensation | $47.6M | $31.8M | $19.1M | $10.3M | $3.8M |
| Capital expenditure | $9.4M | $4.4M | $25.2M | $2.7M | $592,000 |
| Free cash flow | -$58.3M | -$103.6M | -$133.2M | -$83.0M | -$57.9M |
| Impairments | — | — | — | — | $0 |
Shares outstanding 56.9M · Free float 85.7%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.